Floatz logo

Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]

Opioid Use

Medical University of WarsawPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

24 Active assets in the Opioid Use cohort.

Asset / SponsorPhaseRating
METHADONE
Rutgers, The State University of New Jersey
Phase 4BBB
HYDROMORPHON
Endeavor Health
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Wake Forest University Health Sciences
Phase 4BBB
FENTANYL
University of Crete
Phase 4BB
Bxcl501
Kaohsiung Veterans General Hospital.
Phase 4BB

View all 28 →

Same molecule, other indications

Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] is also rated in:

post-operative pain, non-human animalDormant
BB
Indicative ·
65 / 100
View asset →
obesity disorderDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →